BDNF and disorder of sexual differentiation: Thus, BDNF neutralization is likely to enhance urethral synergic relaxation during the voiding phase in SCI mice [35] (Figure 2), suggesting that anti-BDNF therapy is effective for the treatment of SCI-induced DSD whereas anti-NGF therapy is useful for the treatment of DO in the storage phase.